drugset / Trial / NCT07141641

Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access

NCT07141641 ↗

Expanded access Temporarily not available Humacyte, Inc.

Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an ATEV clinical study.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Acellular Tissue Engineered Vessel Unknown — —